WallStreetZenWallStreetZen

NASDAQ: ODTX
Odyssey Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ODTX

Based on 4 analysts offering 12 month price targets for Odyssey Therapeutics Inc

Min Forecast
$29.00+41.39%
Avg Forecast
$35.75+74.31%
Max Forecast
$44.00+114.53%

Should I buy or sell ODTX stock?

Based on 6 analysts offering ratings for Odyssey Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 50%
Buy
3 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ODTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ODTX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their ODTX stock forecasts and price targets.

ODTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-27
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-06-18
lockedlocked$00.00+00.00%2026-06-02
lockedlocked$00.00+00.00%2026-06-02
Wedbush
Top 4%
97
BuyInitiates Coverage On$30.00+46.27%2026-06-02

1 of 1

Forecast return on equity

Is ODTX forecast to generate an efficient return?

Company
-41.43%
Industry
22.19%
Market
168.26%
ODTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ODTX forecast to generate an efficient return on assets?

Company
-36.07%
Industry
23.8%
ODTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ODTX earnings per share forecast

What is ODTX's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$6.11
Avg 2 year Forecast
-$5.08
Avg 3 year Forecast
-$4.96

ODTX revenue forecast

What is ODTX's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

ODTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ODTX$20.51$35.75+74.31%Strong Buy
CRVS$11.62$40.00+244.23%Strong Buy
JANX$16.30$27.88+71.01%Buy
ANL$15.53$30.80+98.33%Strong Buy
GLUE$11.77$27.25+131.52%Strong Buy
View Top Biotech Stocks

Odyssey Therapeutics Stock Forecast FAQ

Is Odyssey Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: ODTX) stock is to Strong Buy ODTX stock.

Out of 6 analysts, 3 (50%) are recommending ODTX as a Strong Buy, 3 (50%) are recommending ODTX as a Buy, 0 (0%) are recommending ODTX as a Hold, 0 (0%) are recommending ODTX as a Sell, and 0 (0%) are recommending ODTX as a Strong Sell.

If you're new to stock investing, here's how to buy Odyssey Therapeutics stock.

What is ODTX's earnings growth forecast for 2026-2028?

(NASDAQ: ODTX) Odyssey Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.78%.

Odyssey Therapeutics's earnings in 2026 is N/A.On average, 8 Wall Street analysts forecast ODTX's earnings for 2026 to be -$293,791,387, with the lowest ODTX earnings forecast at -$344,752,649, and the highest ODTX earnings forecast at -$251,298,038. On average, 8 Wall Street analysts forecast ODTX's earnings for 2027 to be -$244,036,394, with the lowest ODTX earnings forecast at -$331,565,389, and the highest ODTX earnings forecast at -$184,184,305.

In 2028, ODTX is forecast to generate -$238,235,730 in earnings, with the lowest earnings forecast at -$270,338,826 and the highest earnings forecast at -$181,661,232.

What is ODTX's revenue growth forecast for 2026-2028?

(NASDAQ: ODTX) Odyssey Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.

Odyssey Therapeutics's revenue in 2026 is N/A.On average, 8 Wall Street analysts forecast ODTX's revenue for 2026 to be $0, with the lowest ODTX revenue forecast at $0, and the highest ODTX revenue forecast at $0. On average, 8 Wall Street analysts forecast ODTX's revenue for 2027 to be $0, with the lowest ODTX revenue forecast at $0, and the highest ODTX revenue forecast at $0.

In 2028, ODTX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is ODTX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ODTX) forecast ROA is -36.07%, which is lower than the forecast US Biotechnology industry average of 23.8%.

What is ODTX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ODTX price target, the average ODTX price target is $35.75, with the highest ODTX stock price forecast at $44.00 and the lowest ODTX stock price forecast at $29.00.

On average, Wall Street analysts predict that Odyssey Therapeutics's share price could reach $35.75 by Aug 27, 2027. The average Odyssey Therapeutics stock price prediction forecasts a potential upside of 74.31% from the current ODTX share price of $20.51.

What is ODTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ODTX) Odyssey Therapeutics's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that ODTX's EPS will be -$6.11 for 2026, with the lowest EPS forecast at -$7.17, and the highest EPS forecast at -$5.23. On average, analysts forecast that ODTX's EPS will be -$5.08 for 2027, with the lowest EPS forecast at -$6.90, and the highest EPS forecast at -$3.83. In 2028, ODTX's EPS is forecast to hit -$4.96 (min: -$5.63, max: -$3.78).

What is ODTX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ODTX) forecast ROE is -41.43%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.